Looking Into Bio-Path Hldgs's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Bio-Path Holdings (NYSE:BPTH) has seen a decrease in short interest, now at 8.96% of its float, down 4.27% from the last report. With 67 thousand shares sold short, it would take about 1.92 days to cover all short positions. This change in short interest could indicate a shift in market sentiment towards BPTH, potentially signaling a more bullish outlook. The company's short interest is higher than its peer group average of 5.10%, suggesting it is more heavily shorted than similar companies.
May 01, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Bio-Path Holdings' short interest has decreased, suggesting a potential shift in market sentiment towards the stock. With a higher short interest compared to its peers, this could indicate a bullish outlook in the short term.
The decrease in short interest for Bio-Path Holdings suggests that fewer traders are betting against the stock, which could be a sign of increasing confidence in its performance. Given that its short interest is still above the peer group average, this might attract attention from investors looking for potential upside, thus potentially driving up the stock price in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90